Musaffa Logo
Mankind Pharma Ltd MANKIND.NS

Last Updated: Jul 21, 12:00 AM·NSE

MANKIND.NS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Mankind Pharma Ltd is classified as halal.

HALAL

Report Source: 2026 Annual Report

Mankind Pharma Ltd

Mankind Pharma Ltd. Stock Analysis MANKIND.NS

India Health Care Large Cap Report:
Mankind Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations across acute and chronic therapeutic areas. The company is headquartered in New Delhi, Delhi and currently employs 27,000 full-time employees. The company went IPO on 2023-05-09. The firm is engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. The company also offers pet care, crop protection solutions, and veterinary care. The company offers healthcare solutions for a range of healthcare needs with a portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/central nervous system, vitamins, minerals and nutrients, derma, fertility, and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, Rivotril, and others. Its subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Jaspack Industries Private Limited, and others.
Read More

Mankind Pharma Ltd (MANKIND.NS) Chart

Key Statistics of Mankind Pharma Ltd (MANKIND.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹2,559.90₹2,588.20

Today's Open

₹2,579.80

Volume

165.91K

P/E Ratio (TTM)

53.79

52 Week Range

₹1,909.70₹2,694.90

Market Cap

1.05T

Avg. Volume

476.83K

Dividend Yield

-

Financial Metrics & Statements of Mankind Pharma Ltd (MANKIND.NS)

Super Investors Invested in Mankind Pharma Ltd (MANKIND.NS)

FAQ's for Mankind Pharma Ltd (MANKIND.NS)

  • As of July 2026, Mankind Pharma Ltd MANKIND.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Mankind Pharma Ltd using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Mankind Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Mankind Pharma Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Mankind Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Mankind Pharma Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.